Antidepressant Drug Use in Pregnancy

Abstract

Get full access to this article

View all access options for this article.

References

1. Pastuszak A , Schick-Boschetto B , Zuber C , et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993;269:2246 8.

2. Kulin NA , Pastuszak A , Sage SR , et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicenter study. JAMA 1998;279:609 10.

3. Hendrick V , Smith LM , Suri R , et al. Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gy necol 2003;188:812 5.

4. Zeskind PS , Stephens LE . Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pe diatrics 2004;113:368 75.

5. Nulman I , Rowet J , Stewart DE , et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-262.

6. Morrison JL , Rurak DW , Chien C , et al. Maternal fluoxetine infusion does not alter fetal endocrine and hiophysical circadian rhythms in pregnant sheep. J Soc Gynecol Investig 2005;12: 356 64.